Home Compare BOL.PA vs PFE
Stock Comparison · Single-driver result

Bolloré vs Pfizer: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Bolloré SE carrying a narrow edge on growth. Pfizer still has the edge on valuation, which keeps the comparison from looking entirely one-sided. In the market, Pfizer carries the stronger setup — intact trend against Bolloré SE's broken trend. That leaves a split case: the structural lead stays with Bolloré SE, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Most of the separation is still concentrated in growth.

Trajectory Similarity
0.57
Moderately similar
Peer-set rank: #11
within Bolloré SE's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The clearest structural overlap shows up in recent revenue growth and investment intensity.

Similarity drivers
recent revenue growthinvestment intensity
What reduces the match
revenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BOL.PA
Bolloré SE
46
Peer-Score
Signal qualityHigh
vs
PFE
Pfizer Inc.
42
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: BOL.PA vs PFE Profitability 7 12 Stability 74 48 Valuation 39 82 Growth 88 19 BOL.PA PFE
Gap Ranking
#1 Growth +69
#2 Valuation +43
#3 Stability +26
#4 Profitability +5
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BOL.PA and PFE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BOL.PAPFE Relative valuation Structural strength

The setup splits cleanly: structure favours Bolloré SE, while the price setup favours Pfizer Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Bolloré SE ranks near the top of the group on growth; Pfizer Inc. sits in the weaker half.
Valuation
The same broad pattern appears on valuation: Pfizer Inc. ranks near the top of the group, while Bolloré SE stays in the weaker half.
Growth — Dominant Gap
BOL.PA
88
PFE
19
Gap+69in favour of BOL.PA

Earnings growth is one contributing factor within the growth lead.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Pfizer, with a forward P/E that is 29 turns lower there.

What this means for the comparison

The page question resolves through growth, but valuation and current pricing still keep the broader comparison from reading as fully aligned.

Explore full peer positioning in AssetNext

Break down the BOL.PA vs PFE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BOL.PA and PFE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.